tiprankstipranks
Trending News
More News >
Fonar Corp (FONR)
NASDAQ:FONR

Fonar (FONR) Price & Analysis

Compare
90 Followers

FONR Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

12.59%25.56%53.31%
Insiders
25.56% Other Institutional Investors
53.31% Public Companies and
Individual Investors

FONR FAQ

What was Fonar Corp’s price range in the past 12 months?
Fonar Corp lowest stock price was $12.10 and its highest was $18.68 in the past 12 months.
    What is Fonar Corp’s market cap?
    Fonar Corp’s market cap is $76.44M.
      When is Fonar Corp’s upcoming earnings report date?
      Fonar Corp’s upcoming earnings report date is May 19, 2025 which is in 33 days.
        How were Fonar Corp’s earnings last quarter?
        Fonar Corp released its earnings results on Feb 18, 2025. The company reported $0.286 earnings per share for the quarter, beating the consensus estimate of N/A by $0.286.
          Is Fonar Corp overvalued?
          According to Wall Street analysts Fonar Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Fonar Corp pay dividends?
            Fonar Corp does not currently pay dividends.
            What is Fonar Corp’s EPS estimate?
            Fonar Corp’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Fonar Corp have?
            Fonar Corp has 6,211,191 shares outstanding.
              What happened to Fonar Corp’s price movement after its last earnings report?
              Fonar Corp reported an EPS of $0.286 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -7.385%.
                Which hedge fund is a major shareholder of Fonar Corp?
                Currently, no hedge funds are holding shares in FONR
                ---

                Fonar Stock Smart Score

                Company Description

                Fonar Corp

                FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Cutera
                Electromed
                Iridex
                Neurometrix
                Aytu BioScience
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis